Order Article Reprints

Cona MS, Lecchi M, Cresta S, Damian S, Del Vecchio M, Necchi A, Poggi MM, Raggi D, Randon G, Ratta R, et al. Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies. Cancers. 2019; 11(2):223. https://doi.org/10.3390/cancers11020223

Cona, Maria Silvia, Mara Lecchi, Sara Cresta, Silvia Damian, Michele Del Vecchio, Andrea Necchi, Marta Maria Poggi, Daniele Raggi, Giovanni Randon, Raffaele Ratta, and et al. 2019. "Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies" Cancers 11, no. 2: 223. https://doi.org/10.3390/cancers11020223

Cona, M. S., Lecchi, M., Cresta, S., Damian, S., Del Vecchio, M., Necchi, A., Poggi, M. M., Raggi, D., Randon, G., Ratta, R., Signorelli, D., Vernieri, C., de Braud, F., Verderio, P., & Di Nicola, M. (2019). Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies. Cancers, 11(2), 223. https://doi.org/10.3390/cancers11020223